Radical and Radical-Polar Crossover Logic in Terpenoid Synthesis

This project aims to redefine terpenoid biogenesis by demonstrating the interplay of radical and polar reactivity, enabling sustainable synthesis of druggable natural products for medical applications.

Subsidie
€ 1.987.059
2022

Projectdetails

Introduction

The synthesis of complex natural products has shaped the field of organic chemistry, with translational applications spreading further into medicinal, agrochemical, and material sciences. As the largest class of natural products, terpenoids play a variety of roles in mediating antagonistic and beneficial interactions macroscopically, i.e., among organisms, and microscopically, i.e., on a (sub)cellular level.

Role of Terpenoids

They defend many species of plants, animals, and microorganisms against predators, pathogens, and competitors, and they are involved in conveying messages within these organisms.

Objectives of the Project

Facilitating and streamlining access to the most complex terpenoids, heavily rearranged and highly oxidized triterpenoids, requires an understanding of Nature’s ways to biosynthesize these structures, i.e., of their biogenesis. Biomimetic synthesis can only then provide routes which outrival classical retrosynthetic planning. In the absence of a plausible biogenesis proposal, this strategy is not accessible, though.

Current Paradigms

So far, biogenesis proposals have, in lieu of validated intermediates and enzymes, followed the paradigm of polar mechanisms and evoked standard textbook reactions involving ionic intermediates to account for skeletal rearrangements.

Project Aim

The aim of this project is to disprove this paradigm and cross this perceived limit of reactivity. Thus, we will here provide chemical proof that terpenoid biogenesis is not sufficiently explained by polar mechanisms, but rather is an intricate interplay of radical and polar reactivity.

Crossing Boundaries

The border we attempt to cross is the one between two very different chemical entities: radicals and ions.

Development of New Strategies

Development of radical-polar crossover logic will evolve robust and selective routes to access druggable triterpenoid natural products modulating the immune system, targeting cancer, and combating pathogens.

Added Value

Added value comes from the involvement of modern photoredox catalysis strategies to initiate radical-polar crossover cascades in a sustainable fashion.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.987.059
Totale projectbegroting€ 1.987.059

Tijdlijn

Startdatum1-5-2022
Einddatum30-4-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVERpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Decoding the Biochemistry of Terpene Synthases

The TerpenCode project aims to utilize deep learning models to predict and engineer terpene synthases, enhancing enzyme design for sustainable biotechnological production of novel chemicals.

€ 2.158.732
ERC Starting...

Designing organic molecules as platforms for reversible charge-to-spin conversion with applications in chromophore optimisation and drug discovery

This project aims to explore reversible diradical formation in donor-acceptor organic molecules to enhance light-emitting materials and drug discovery through novel design criteria.

€ 1.498.361
ERC Advanced...

Energy Transfer Catalysis: A Highway to Molecular Complexity

HighEnT aims to innovate synthetic methodologies using visible light-mediated EnT catalysis to create complex organic molecules for pharmacological applications, enhancing chemical space and reaction design.

€ 2.499.250
ERC Consolid...

Enzymatic chemistry acting on alkyl chains

The project aims to discover and characterize novel biocatalysts from cyanobacteria to enable selective functionalization of alkyl chains for sustainable production of organic chemicals.

€ 1.995.621
ERC Advanced...

New Catalysts for Synthesis of Stereodefined and Modifiable Tetrasubstituted Alkenes

Develop novel Mo and W catalysts for efficient olefin metathesis to produce versatile tetrasubstituted olefins with multiple modifiable substituents for drug discovery applications.

€ 1.651.250